Vandetanib Fumarate is an oral small molecule tyrosine kinase inhibitor targeting RET, VEGFR, and EGFR, key pathways in thyroid cancer. It is widely used in preclinical research for investigating oncogenic signaling in both in vitro cellular assays and in vivo xenograft models.
Molecular Weight:
591.43
CAS Number:
[338992-00-0]
Formula:
C26H28BrFN4O6
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted